High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Around 25 percent of U.S. adults said they would consider using prescription weight loss medications, like Ozempic or Wegovy, ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Novo Nordisk, the manufacturer behind Ozempic and Wegovy, has another weight loss medication in the works with some ...

The Danish-based company has just revealed preliminary data suggesting that its experimental drug amycretin can help people ...

Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...